Toxic anterior segment syndrome outbreak after vitrectomy and silicone oil injection

Purpose To report a rare outbreak of toxic anterior segment syndrome (TASS) in 4 patients who underwent vitrectomy with silicone oil injection. Methods Review of the medical charts of all patients who underwent surgery in the operating theater of our department during a 10-day period in May 2011. Results We report on 4 patients who developed TASS after vitrectomy with silicone oil injection. The clinical presentation was typical of TASS, and different from the anterior chamber reaction that may occur after silicone oil injection. All cases were treated effectively with topical steroids, and the outbreak stopped after the silicone oil batch was exchanged. Conclusions We discuss the possible mechanisms for this unusual TASS outbreak, and suggest the silicone oil as its cause.

[1]  A. Mistretta,et al.  HEAVY VERSUS STANDARD SILICONE OIL IN THE MANAGEMENT OF RETINAL DETACHMENT WITH MACULAR HOLE IN MYOPIC EYES , 2011, Retina.

[2]  Y. Qi,et al.  COMPLICATIONS AFTER HEAVY SILICONE OIL TAMPONADE IN COMPLICATED RETINAL DETACHMENT , 2011, Retina.

[3]  C. Danford,et al.  Toxic anterior segment syndrome: Common causes , 2010, Journal of cataract and refractive surgery.

[4]  J. Andonegui,et al.  Brote de síndrome tóxico del segmento anterior después de cirugía vítrea , 2009 .

[5]  D. Aliseda,et al.  [Outbreak of toxic anterior segment syndrome after vitreous surgery]. , 2009, Archivos de la Sociedad Espanola de Oftalmologia.

[6]  H. Heimann,et al.  Heavy tamponade 1: a review of indications, use, and complications , 2008, Eye.

[7]  A. Mathis,et al.  Efficacy and safety of heavy silicone oil Densiron 68® in the treatment of complicated retinal detachment with large inferior retinectomy , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[8]  D. Morck,et al.  Update on toxic anterior segment syndrome , 2007, Current opinion in ophthalmology.

[9]  Nick Mamalis.  Toxic anterior segment syndrome. , 2006, Journal of cataract and refractive surgery.

[10]  M. Cellini,et al.  Topical treatment of postvitrectomy fibrin formation with tissue plasminogen activator , 2004, International Ophthalmology.

[11]  N. Erol,et al.  Treatment of intracameral fibrinous membranes with tissue plasminogen activator. , 2003, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[12]  P. Versura,et al.  The Biocompatibility of Silicone, Fluorosilicone and Perfluorocarbon Liquids as Vitreous Tamponades , 2001, Ophthalmologica.

[13]  M. Kamei,et al.  Tissue Plasminogen Activator in the Treatment of Vitreoretinal Diseases , 2000, Seminars in ophthalmology.

[14]  H. Flynn,et al.  Transient hypopyon with marked anterior chamber fibrin following pars plana vitrectomy and silicone oil injection. , 1989, Archives of ophthalmology.